Cure&Sure Biotech Co., LTD: Clinical Trials

5 trials sponsored by Cure&Sure Biotech Co., LTD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 1 completed. 4 Phase 2, 3 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 4
Phase 13Unknown 2, Completed 1
Phase 31Unknown 1

Follow Cure&Sure Biotech Co., LTD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Liver Cancer
gp96 - Liver Cancer
Phase 2 / Phase 3UnknownCure&Sure Biotech Co., LTD802019-12-192019-12-20
A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96
gp96, Temozolomide, radiotherapy - Glioma of Brain
Phase 2UnknownCure&Sure Biotech Co., LTD1502019-08-212020-03-12
Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96
autologous gp96 vaccination, Oxaliplatin+S-1 - Gastric Carcinoma
Phase 1 / Phase 2UnknownChinese PLA General Hospital452014-11-012016-06-06
Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96
gp96 - Glioma
Phase 1CompletedCure&Sure Biotech Co., LTD202013-07-012017-11-17
Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96
autologous gp96 vaccination - Liver Cancer, Pancreatic Adenocarcinoma
Phase 1 / Phase 2UnknownCure&Sure Biotech Co., LTD202012-03-012015-12-11

Conditions studied

Liver Neoplasms (2)  ·  Glioma (1)  ·  Stomach Neoplasms (1)

Interventions

glucose-regulated proteins (3)  ·  Heat-Shock Response (1)  ·  Radiotherapy (1)  ·  Temozolomide (1)  ·  vitespin (1)

Countries

China (4)

Top investigators

Jianqiang Cai, meidical (1)  ·  Lei Yu, medical (1)  ·  Lin Chen, MD (1)  ·  Zhixian Gao, Doctor (1)

Results publications

PMID 29769450